Barclays
GDRX icon

Barclays’s GoodRx Holdings GDRX Stock Holding History

Barclays’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-97,500
Closed -$454K – 5179
2022
Q4 		$454K Buy
+97,500
New +$480K ﹤0.01% 3374

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Barclays's GDRX Position: Q1 2026 in Review

Barclays reduced its GoodRx Holdings (GDRX) stake by 36% in Q1 2026, selling an estimated $265K and leaving 199,555 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

Barclays first reported a position in GDRX in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.32M in Q3 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Barclays held 199,555 shares of GoodRx Holdings worth $391K as of Q1 2026.
  • Barclays sold 112,910 GoodRx Holdings shares in Q1 2026, an estimated $265K.
  • GoodRx Holdings made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3329 holding.
  • Barclays first reported a position in GoodRx Holdings in Q1 2022 and has held it in 17 quarters since.
  • Barclays's GoodRx Holdings position peaked at $1.32M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.